Skip to main content

Table 4 Performance of clinical decision rules at the end of calendar day 3 following admission to the critical care unit in the full validation sample

From: Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units

Rule

Percentage ‘high risk’

Sensitivity (95 % CI)

Specificity (95 % CI)

PPV (95 % CI)

NPV (95 % CI)

FIRE Study

 F1

27.1

54.1 (36.9, 70.5)

73.0 (72.0, 73.9)

0.87 (0.53, 1.34)

99.7 (99.6, 99.8)

 F2

15.7

40.5 (24.8, 57.9)

84.5 (83.7, 85.2)

1.13 (0.63, 1.85)

99.7 (99.5, 99.8)

 F3

6.4

24.3 (11.8, 41.2)

93.6 (93.1, 94.2)

1.65 (0.76, 3.11)

99.6 (99.5, 99.8)

Ostrosky-Zeichner et al., 2007 [6]

 OZ1

58.5

86.5 (71.2, 95.5)

41.6 (40.5, 42.7)

0.64 (0.44, 0.91)

99.9 (99.7, 100)

 OZ2

43.4

81.1 (64.8, 92.0)

56.7 (55.7, 57.8)

0.81 (0.55, 1.16)

99.9 (99.7, 99.9)

 OZ3

21.1

51.4 (34.4, 68.1)

79.1 (78.2, 79.9)

1.06 (0.64, 1.65)

99.7 (99.6, 99.8)

Paphitou et al., 2005 [7]

 P1

29.0

43.2 (27.1, 60.5)

71.0 (70.1, 72.0)

0.65 (0.37, 1.05)

99.7 (99.5, 99.8)

 P2

83.2

97.3 (85.8, 99.9)

16.8 (16.0, 17.7)

0.51 (0.36, 0.71)

99.9 (99.6, 100)

 P3

23.3

43.2 (27.1, 60.5)

76.8 (75.9, 77.7)

0.81 (0.46, 1.31)

99.7 (99.5, 99.8)

  1. CI confidence interval, NPV negative predictive value, PPV positive predictive value